CL
AVXL icon

Choreo LLC’s Anavex Life Sciences AVXL Stock Holding History

Choreo LLC’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.9K Sell
29,709
-1,790
-6% -$5.3K ﹤0.01% 1625
2026
Q1 		$96.7K Sell
31,499
-492
-2% -$2.13K ﹤0.01% 1541
2025
Q4 		$122K Sell
31,991
-957
-3% -$5.86K ﹤0.01% 1499
2025
Q3 		$293K Sell
32,948
-463
-1% -$4.7K ﹤0.01% 1242
2025
Q2 		$308K Buy
33,411
+10,789
+48% +$92.1K ﹤0.01% 1156
2025
Q1 		$194K Buy
+22,622
New +$214K ﹤0.01% 1319

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Choreo LLC's AVXL Position: Q2 2026 in Review

Choreo LLC reduced its Anavex Life Sciences (AVXL) stake by 5.7% in Q2 2026, selling an estimated $5.3K and leaving 29,709 shares worth $76.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Choreo LLC first reported a position in AVXL in Q1 2025 and has held it in 6 quarters since. The position peaked at $308K in Q2 2025. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Choreo LLC held 29,709 shares of Anavex Life Sciences worth $76.9K as of Q2 2026.
  • Choreo LLC sold 1,790 Anavex Life Sciences shares in Q2 2026, an estimated $5.3K.
  • Anavex Life Sciences made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1625 holding.
  • Choreo LLC first reported a position in Anavex Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • Choreo LLC's Anavex Life Sciences position peaked at $308K in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.